Cutaneous manifestations in COVID-19: familial cluster of urticarial rash.
作者信息
Cepeda-Valdes R, Carrion-Alvarez D, Trejo-Castro A, Hernandez-Torre M, Salas-Alanis J
机构信息
Department of Basic Science, Universidad de Monterrey, Monterrey, Mexico.
Department of Health Sciences, Universidad de Monterrey, San Pedro Garza Garcia, Nuevo León, Mexico.
出版信息
Clin Exp Dermatol. 2020 Oct;45(7):895-896. doi: 10.1111/ced.14290. Epub 2020 Jun 22.
Abstract
摘要
相似文献
1
Cutaneous manifestations in COVID-19: familial cluster of urticarial rash.新型冠状病毒肺炎的皮肤表现：家族性荨麻疹皮疹聚集
Clin Exp Dermatol. 2020 Oct;45(7):895-896. doi: 10.1111/ced.14290. Epub 2020 Jun 22.
2
Severe urticarial rash as the initial symptom of COVID-19 infection.严重荨麻疹样皮疹为 COVID-19 感染的初始症状。
BMJ Case Rep. 2021 Mar 25;14(3):e241793. doi: 10.1136/bcr-2021-241793.
3
Urticarial vasculitis secondary to H1N1 vaccination.甲型H1N1流感疫苗接种继发的荨麻疹性血管炎
Acta Derm Venereol. 2010 Nov;90(6):651-2. doi: 10.2340/00015555-0950.
4
Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria.低剂量全身类固醇，一种治疗 COVID-19 相关荨麻疹的新兴治疗选择。
J Dermatolog Treat. 2022 Mar;33(2):1140-1141. doi: 10.1080/09546634.2020.1795062. Epub 2020 Jul 16.
5
Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.年龄相关的 SARS-CoV-2 进入位点在小鼠化学感觉系统中的出现反映了 COVID-19 嗅觉味觉丧失症状。
Commun Biol. 2021 Jul 15;4(1):880. doi: 10.1038/s42003-021-02410-9.
6
D-dimer: a biomarker for antihistamine-resistant chronic urticaria.D-二聚体：一种对抗组胺药耐药的慢性荨麻疹的生物标志物。
J Allergy Clin Immunol. 2013 Oct;132(4):983-6. doi: 10.1016/j.jaci.2013.04.037. Epub 2013 Jun 12.
7
Clinical efficacy of reserpine as "add-on therapy" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.利血平作为抗组胺药的“附加疗法”用于顽固性慢性特发性荨麻疹和荨麻疹性血管炎患者的临床疗效。
J Dermatol. 2010 Sep;37(9):827-9. doi: 10.1111/j.1346-8138.2010.00881.x.
8
Retrospective chart review in a cohort of patients with urticarial dermatitis.对一组荨麻疹性皮炎患者进行回顾性病历审查。
Australas J Dermatol. 2014 May;55(2):137-9. doi: 10.1111/ajd.12088. Epub 2013 Jun 28.
9
Urticarial vasculitis: a retrospective study of 15 cases.荨麻疹性血管炎：15例回顾性研究
Actas Dermosifiliogr. 2013 Sep;104(7):579-85. doi: 10.1016/j.adengl.2012.12.005. Epub 2013 Jul 23.
10
Urticarial vasculitis presenting as erythema gyratum repens-like eruption.表现为回状红斑样皮疹的荨麻疹性血管炎。
J Eur Acad Dermatol Venereol. 2009 Feb;23(2):215-7. doi: 10.1111/j.1468-3083.2008.02798.x. Epub 2008 May 12.
引用本文的文献
1
Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic.定义 COVID-19 的短期和长期皮肤表现：大流行三年多后的洞察。
Rom J Morphol Embryol. 2023 Jul-Sep;64(3):291-304. doi: 10.47162/RJME.64.3.01.
2
Cutaneous Manifestation in COVID-19: A Lesson Over 2 Years Into the Pandemic.COVID-19 相关皮肤表现：大流行 2 年多来的教训。
Clin Med Res. 2023 Mar;21(1):36-45. doi: 10.3121/cmr.2023.1598.
3
Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections.严重急性呼吸综合征冠状病毒（SARS-CoV）、中东呼吸综合征冠状病毒（MERS-CoV）和严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染诱导的细胞因子风暴和免疫反应特征比较
J Inflamm Res. 2021 Oct 23;14:5475-5487. doi: 10.2147/JIR.S329697. eCollection 2021.
4
A systematic review of dermatologic manifestations among adult patients with COVID-19 diagnosis.对确诊为COVID-19的成年患者皮肤表现的系统评价。
Skin Health Dis. 2021 Jun;1(2):e20. doi: 10.1002/ski2.20. Epub 2021 Mar 19.
5
Prevalence and pattern of acute dermatological manifestations of the novel COVID-19 infection at a COVID-19 treatment center in Sub-Saharan Africa.撒哈拉以南非洲一家新冠病毒疾病治疗中心新型冠状病毒感染急性皮肤表现的患病率及模式
Dermatol Ther. 2021 May;34(3):e14953. doi: 10.1111/dth.14953. Epub 2021 Mar 23.
6
Cutaneous manifestations and dermatological sequelae of Covid-19 infection compared to those from other viruses.Covid-19 感染的皮肤表现和皮肤病学后遗症与其他病毒相比。
Australas J Dermatol. 2021 May;62(2):141-150. doi: 10.1111/ajd.13561. Epub 2021 Feb 17.
7
Skin manifestations of COVID-19: A worldwide review.新型冠状病毒肺炎的皮肤表现：一项全球综述。
JAAD Int. 2021 Mar;2:119-133. doi: 10.1016/j.jdin.2020.12.003. Epub 2020 Dec 16.
8
Inflammation and Vascular Injury as the Basis of COVID-19 Skin Changes: Preliminary Analysis of 23 Patients from the Literature.炎症和血管损伤作为新冠病毒病皮肤改变的基础：来自文献的23例患者的初步分析
Clin Cosmet Investig Dermatol. 2021 Jan 6;14:1-7. doi: 10.2147/CCID.S278833. eCollection 2021.
9
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.在 COVID-19 期间发生的慢性炎症和自身免疫性疾病的 JANUS-系统综述文献。
J Autoimmun. 2021 Feb;117:102592. doi: 10.1016/j.jaut.2020.102592. Epub 2020 Dec 14.
10
Cutaneous manifestations of coronavirus disease 2019 in 458 confirmed cases: A systematic review.458例2019冠状病毒病确诊病例的皮肤表现：一项系统综述。
J Family Med Prim Care. 2020 Sep 30;9(9):4563-4569. doi: 10.4103/jfmpc.jfmpc_872_20. eCollection 2020 Sep.
本文引用的文献
1
Cutaneous manifestations in COVID-19: Lessons learned from current evidence.新型冠状病毒肺炎的皮肤表现：从当前证据中吸取的教训
J Am Acad Dermatol. 2020 Jul;83(1):e57-e60. doi: 10.1016/j.jaad.2020.04.094. Epub 2020 Apr 24.
2
Reply to "COVID-19 can present with a rash and be mistaken for dengue": Petechial rash in a patient with COVID-19 infection.对《COVID-19可出现皮疹并被误诊为登革热》的回复：1例COVID-19感染患者的瘀点疹
J Am Acad Dermatol. 2020 Aug;83(2):e141-e142. doi: 10.1016/j.jaad.2020.04.016. Epub 2020 Apr 10.
3
A dermatologic manifestation of COVID-19: Transient livedo reticularis.新型冠状病毒肺炎的一种皮肤表现：暂时性网状青斑。
J Am Acad Dermatol. 2020 Aug;83(2):700. doi: 10.1016/j.jaad.2020.04.018. Epub 2020 Apr 10.
4
Cutaneous manifestations in COVID-19: a first perspective.新型冠状病毒肺炎的皮肤表现：初步观点
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件